Exercise and Coronary Heart Disease Risk Markers in Male Smokers and Non-Smokers
Acute Exercise and Coronary Heart Disease Risk Markers in Healthy Male Smokers and Non-Smokers
1 other identifier
interventional
24
1 country
1
Brief Summary
The present study will investigate the effect of acute exercise on fasting and postprandial risk markers for coronary heart disease (CHD) in healthy male cigarette smokers and non-smokers. Participants will complete two, 2-day trials in a random crossover design separated by an interval of at least 1 week. On day 1, participants will rest (control) or complete 60 minute of treadmill exercise at 60% of maximum oxygen uptake (exercise). On day 2, participants will rest and consume two high fat meals (breakfast and lunch) over an 8-h period during which 13 venous blood samples and nine blood pressure measurements will be taken at pre-determined intervals. It is hypothesised that men who smoke cigarettes will exhibit impaired fasting and postprandial metabolic risk markers compared to non-smokers, but a single bout of exercise will be equally, if not more, efficacious for improving the CHD risk factor profile in smokers than non-smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 2, 2018
CompletedFirst Submitted
Initial submission to the registry
October 30, 2018
CompletedFirst Posted
Study publicly available on registry
November 8, 2018
CompletedNovember 9, 2018
November 1, 2018
1.2 years
October 30, 2018
November 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Triacylglycerol concentration
Total area under the plasma triacylglycerol concentration versus time curve on day 2
8 hours (Plasma samples will be collected at 0 (fasted), 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8 hours)
Secondary Outcomes (14)
Glucose concentration
8 hours (Plasma samples will be collected at 0 (fasted), 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8 hours)
Insulin concentration
8 hours (Plasma samples will be collected at 0 (fasted), 0.5, 1, 3, 4, 4.5, 6, 8 hours)
Homeostasis model assessment of insulin resistance (HOMA-IR)
Fasting (Plasma samples will be collected at 0 (fasted) hours)
Non-esterified fatty acids concentration
8 hours (Plasma samples will be collected at 0 (fasted), 0.5, 1, 3, 4, 4.5, 6, 8 hours)
Total cholesterol concentration
Fasting (Plasma samples will be collected at 0 (fasted) hours)
- +9 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONParticipants will rest in the laboratory on day 1 and day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.
Exercise
EXPERIMENTALParticipants will complete 60 min of treadmill exercise on day 1 (14:30-15:30). Participants will rest in the laboratory for the remainder of day 1 and throughout day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.
Interventions
Eligibility Criteria
You may qualify if:
- to 45-year-old healthy male smokers or non-smokers;
- Be able to exercise continuously for 1 hour;
- Body mass index between 18.5 and 29.9 kg/m2;
- Weight stable for the past 3 months;
- No known contradictions to maximal exertion exercise (e.g., recent musculoskeletal injury, congenital heart disease).
- A regular cigarette smoker or non-smoker for the last 12 months according to the definition below;
- The National Health Interview Survey (NHIS) definitions will be used to identify cigarette smokers and non-smokers (Link: NHIS Adult Tobacco Use):
- Current smokers will be defined as an adult who has smoked ≥100 cigarettes in their lifetime and who currently smokes cigarettes every day.
- Non-smokers will be defined as an adult who has never smoked or who has smoked \< 100 cigarettes in their lifetime
- The following questions will determine the eligibility and group allocation:
- Do you currently smoke cigarettes on a daily basis?
- Have you smoked at least 100 cigarettes in your entire life?
- If the person answers YES to Q1 and YES to Q2 they are eligible for the study and will be allocated to the smokers group.
- If the person answers NO to Q1 and NO to Q2 they are eligible for the study and will be allocated to the non-smokers group.
- Individuals answering any other combination (YES, NO or NO, YES) will not be eligible to take part in the study.
You may not qualify if:
- Not meeting the criteria for a smoker or non-smoker (defined above);
- Current E-Cigarette smoker;
- Musculoskeletal injury that has affected normal ambulation within the last month;
- Any muscle or bone injuries that do not allow them to walk and run on a treadmill;
- Uncontrolled exercise-induced asthma;
- Heart conditions;
- Coagulation or bleeding disorders;
- Diabetes (metabolism will be different to non-diabetics potentially skewing the data);
- Taking any medication that might influence fat metabolism;
- Taking any medication that might influence blood glucose (e.g., insulin for diabetes);
- Dieting or restrained eating behaviours;
- Weight fluctuation greater than 3 kg in the 3 months prior to study enrolment;
- A food allergy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Loughborough Universitylead
- University of Leicestercollaborator
- University Hospitals, Leicestercollaborator
Study Sites (1)
Loughborough University
Loughborough, Leicestershire, LE11 3TU, United Kingdom
Related Publications (4)
Arjunan SP, Deighton K, Bishop NC, King J, Reischak-Oliveira A, Rogan A, Sedgwick M, Thackray AE, Webb D, Stensel DJ. The effect of prior walking on coronary heart disease risk markers in South Asian and European men. Eur J Appl Physiol. 2015 Dec;115(12):2641-51. doi: 10.1007/s00421-015-3269-7. Epub 2015 Oct 5.
PMID: 26438068BACKGROUNDArjunan SP, Bishop NC, Reischak-Oliveira A, Stensel DJ. Exercise and coronary heart disease risk markers in South Asian and European men. Med Sci Sports Exerc. 2013 Jul;45(7):1261-8. doi: 10.1249/MSS.0b013e3182853ecf.
PMID: 23470315BACKGROUNDMiyashita M, Burns SF, Stensel DJ. Accumulating short bouts of brisk walking reduces postprandial plasma triacylglycerol concentrations and resting blood pressure in healthy young men. Am J Clin Nutr. 2008 Nov;88(5):1225-31. doi: 10.3945/ajcn.2008.26493.
PMID: 18996856BACKGROUNDAlotaibi TF, Thackray AE, Roberts MJ, Alanazi TM, Bishop NC, Wadley AJ, King JA, O'Donnell E, Steiner MC, Singh SJ, Stensel DJ. Acute Running and Coronary Heart Disease Risk Markers in Male Cigarette Smokers and Nonsmokers: A Randomized Crossover Trial. Med Sci Sports Exerc. 2021 May 1;53(5):1021-1032. doi: 10.1249/MSS.0000000000002560.
PMID: 33196606DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Stensel
Loughborough University
- PRINCIPAL INVESTIGATOR
Tareq Alotaibi
Loughborough University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 30, 2018
First Posted
November 8, 2018
Study Start
August 4, 2017
Primary Completion
October 2, 2018
Study Completion
October 2, 2018
Last Updated
November 9, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share